| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/18/1997 | US5604127 Probiotic for control of Salmonella in fowl produced by continuous culture of fecal/cecal material |
| 02/18/1997 | US5603930 Lactobacillus johnsonii CNCM I-1225 |
| 02/13/1997 | WO1997005266A1 Methods and means for targeted gene delivery |
| 02/13/1997 | WO1997005255A2 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | WO1997005244A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997004804A1 Avirulent herpetic viruses useful as tumoricidal agents and vaccines |
| 02/13/1997 | WO1997004803A1 Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine |
| 02/13/1997 | WO1997004802A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | WO1997004720A1 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 02/13/1997 | WO1997004647A1 Methods of detecting duplication mutated fibrillin-1 gene and compositions and methods of using the same |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | WO1996034969A3 Gene therapy using replication competent targeted adenoviral vectors |
| 02/13/1997 | CA2228176A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | CA2227972A1 Mocarhagin, a cobra venom protease and therapeutic uses thereof |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2225551A1 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | CA2224907A1 Methods and means for targeted gene delivery |
| 02/12/1997 | EP0758021A2 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds, new inhibitor compounds, and the therapeutic use thereof |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0757717A1 Papillomavirus vaccines |
| 02/12/1997 | EP0757557A1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/12/1997 | CN1142773A Probiotic for control of salmonella |
| 02/12/1997 | CN1142396A Medical composition for drug dependence and preparation thereof |
| 02/12/1997 | CN1142393A Preparation and usage of reducing viscosity Chinese medicine capsule |
| 02/12/1997 | CN1142382A Prescription of health-care restorative spirit and production thereof |
| 02/12/1997 | CN1142370A Capsule for cerebral arteriosclerosis |
| 02/12/1997 | CN1142369A Nutrient health paste |
| 02/12/1997 | CN1142362A Prescription and usage of Chuerjing eye drop |
| 02/12/1997 | CN1142361A Medicine "hadiantala" |
| 02/12/1997 | CN1033998C Medicine for treating arthritis and its preparation |
| 02/12/1997 | CN1033997C Method for prepn. of pigeon milk nutritious |
| 02/11/1997 | US5602301 Non-human mammal having a graft and methods of delivering protein to myocardial tissue |
| 02/11/1997 | US5602183 Diaper dermatitis; mixture of antiinflammatory agent andpyruvate compound, antioxidant and fatty acids |
| 02/11/1997 | US5602109 Feeding human infant dietary formula that alleviates diarrhea; contains ribonucleotides |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601999 Antitumor polysaccharide-glycan complexes |
| 02/11/1997 | US5601989 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 02/11/1997 | US5601972 Separating plasma from red cells while retaining residual plasma, adding biologically compatible solution having specified effective osmolality |
| 02/11/1997 | US5601828 CD8 derivatives and methods of use for cellular modulation and enhancement of cellular engraftment |
| 02/11/1997 | US5601818 Administering transformed cancer cells which carry the herpes simplex virus gene for thymidine kinase and are susceptible to an antiviral nucleoside analog, then administering the nucleosside analog to cause tumor regression |
| 02/11/1997 | US5601730 Process and apparatus for removal of unwanted fluids from processed blood products |
| 02/06/1997 | WO1997004119A1 Viral vectors and line for gene therapy |
| 02/06/1997 | WO1997004099A2 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997004093A1 Nucleotide and peptide sequences for treating myasthenia |
| 02/06/1997 | WO1997004092A1 P53 protein variants and therapeutical uses thereof |
| 02/06/1997 | WO1997004085A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 02/06/1997 | WO1997003995A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | WO1997003706A1 Method and apparatus for inactivating contaminants in blood products |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003684A1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 02/06/1997 | WO1997003683A1 Treatment of scleroderma and related diseases |
| 02/06/1997 | WO1997003653A1 Enterogenin pharmaceutical form |
| 02/06/1997 | DE19540515C1 Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten Tumor therapy by adoptive transfer CD44v-specific cytotoxic T lymphocytes |
| 02/06/1997 | CA2227592A1 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 02/06/1997 | CA2227334A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | CA2227220A1 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | CA2200696A1 Viral vectors and line for gene therapy |
| 02/06/1997 | CA2200295A1 Enterogenin pharmaceutical form |
| 02/05/1997 | EP0756636A1 Chondroitinases i and ii, methods of preparation, and use thereof |
| 02/05/1997 | EP0756490A1 Human bone stimulating factor |
| 02/05/1997 | EP0756487A1 Method for implanting encapsulated cells in a host |
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1142187A Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 02/05/1997 | CN1142186A Use of IL-10 to stimulate peripheral blood mononuclear cell cytolytic activity |
| 02/05/1997 | CN1141805A Chinese medicine for treatment of angiitis |
| 02/05/1997 | CN1141800A Eyedrops for treatment of cataract and production technology thereof |
| 02/05/1997 | CN1141791A Ointment for treatment of bone tuberculosis |
| 02/05/1997 | CN1141784A Anti-cancer medicine and preparation method thereof |
| 02/05/1997 | CN1141780A Human-body purifying agent |
| 02/05/1997 | CN1141776A Calcium-supplementing oral liquor and preparation method thereof |
| 02/05/1997 | CN1141775A Biochemical medicine made from human-embryo |
| 02/05/1997 | CN1141767A Medical product containing organic ash content capable of emitting far infrared |
| 02/05/1997 | CN1141745A Jujube health-care drink and preparation method thereof |
| 02/05/1997 | CN1141742A Drink of shark cartilage and processing method thereof |
| 02/04/1997 | US5599795 Method for treatment of idiopathic inflammatory bowel disease (IIBD) |
| 02/04/1997 | US5599791 Bactericide active against gramnegative and grampositive bacteria |
| 02/04/1997 | US5599703 In vitro amplification/expansion of CD34+ stem and progenitor cells |
| 02/04/1997 | US5599682 Method for the protection of leucocytes and method of blood analysis |
| 02/04/1997 | US5599558 Selecting amounts of platelet releasate for efficacious treatment of tissue |
| 02/04/1997 | US5599388 Acid resistant calcium carbonate composition containing an aluminum salt, uses therefor and processes for its production |
| 01/30/1997 | WO1997003192A2 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | WO1997003186A2 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997002836A1 Clostridium difficile toxins as mucosal adjuvants |
| 01/30/1997 | WO1997002828A1 Novel compositions containing phosphoglycero ethers, and use thereof for treating neurodegenerative diseases |
| 01/30/1997 | WO1996039840A3 Treatment of soil and plants with a composition containing bacillus laterosporus |
| 01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | CA2226490A1 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 01/30/1997 | CA2226339A1 Clostridium difficile toxins as mucosal adjuvants |
| 01/30/1997 | CA2226255A1 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/29/1997 | EP0756010A2 Method for detecting, identifying, and quantitating organisms and viruses |
| 01/29/1997 | EP0755683A1 Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen |
| 01/29/1997 | EP0755517A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
| 01/29/1997 | EP0755516A1 A method for detecting and/or quantifying and/or separating apoptotic cells in or from a sample |